These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2869851)

  • 41. Efficacy of cyclo-oxygenase-2 inhibition by etoricoxib and naproxen on the axial manifestations of ankylosing spondylitis in the presence of peripheral arthritis.
    Gossec L; van der Heijde D; Melian A; Krupa DA; James MK; Cavanaugh PF; Reicin AS; Dougados M
    Ann Rheum Dis; 2005 Nov; 64(11):1563-7. PubMed ID: 15731291
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behcet's syndrome.
    Moll JM; Haslock I; Macrae IF; Wright V
    Medicine (Baltimore); 1974 Sep; 53(5):343-64. PubMed ID: 4604133
    [No Abstract]   [Full Text] [Related]  

  • 43. Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis: comment on the article by Clegg et al.
    Helliwell PS
    Arthritis Rheum; 1997 Oct; 40(10):1911-2. PubMed ID: 9336437
    [No Abstract]   [Full Text] [Related]  

  • 44. Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.
    Tsai WC; Chen CJ; Yen JH; Liu HW
    Clin Rheumatol; 2002 Aug; 21(4):339-40. PubMed ID: 12296286
    [No Abstract]   [Full Text] [Related]  

  • 45. Focal sialadenitis in patients with ankylosing spondylitis and spondyloarthropathy: a comparison with patients with rheumatoid arthritis or mixed connective tissue disease.
    Helenius LM; Hietanen JH; Helenius I; Kautiainen H; Piirainen H; Paimela L; Lappalainen M; Suuronen R; Lindqvist C; Leirisalo-Repo M
    Ann Rheum Dis; 2001 Aug; 60(8):744-9. PubMed ID: 11454637
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Circulating inhibitor bound elastase in patients with ankylosing spondylitis and rheumatoid arthritis and the influence of sulphasalazine treatment.
    Feltelius N; Hällgren R
    Ann Rheum Dis; 1988 Jan; 47(1):10-4. PubMed ID: 2894204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Raised circulating levels of the eosinophil cationic protein in ankylosing spondylitis: relation with the inflammatory activity and the influence of sulphasalazine treatment.
    Feltelius N; Hällgren R; Venge P
    Ann Rheum Dis; 1987 May; 46(5):403-7. PubMed ID: 2884933
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.
    van der Horst-Bruinsma IE; Clegg DO; Dijkmans BA
    Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S67-70. PubMed ID: 12463451
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Non-steroidal anti-inflammatory agents (NSAID): when? how?].
    Grassi W; Pauri A
    Clin Ter; 1983 Jan; 104(2):143-50. PubMed ID: 6602684
    [No Abstract]   [Full Text] [Related]  

  • 50. Sulphasalazine and ankylosing spondylitis.
    McConkey B
    Br J Rheumatol; 1990 Feb; 29(1):2-3. PubMed ID: 1968352
    [No Abstract]   [Full Text] [Related]  

  • 51. Conventional DMARD therapy (methotrexate-sulphasalazine) may decrease the requirement of biologics in routine practice of ankylosing spondylitis patients: a real-life experience.
    Can M; Aydın SZ; Niğdelioğlu A; Atagündüz P; Direskeneli H
    Int J Rheum Dis; 2012 Dec; 15(6):526-30. PubMed ID: 23253235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Should tests for proteinuria be included in the monitoring schedule of sulphasalazine?
    Helliwell PS
    Br J Rheumatol; 1995 Aug; 34(8):790-1. PubMed ID: 7551669
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Successful adalimumab treatment and usefulness of capsule endoscopy for gut inflammation concomitant with ankylosing spondylitis.
    Ota S; Sakuraba H; Hiraga H; Hasui K; Satake M; Hanabata N; Akemoto Y; Watanabe R; Tanaka N; Ishiguro Y; Tanaka M; Fukuda S
    Mod Rheumatol; 2019 Jul; 29(4):708-713. PubMed ID: 28271948
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Persistence of enthesopathic changes in patients with spondylarthropathy during a 6-month follow-up.
    Lehtinen A; Leirisalo-Repo M; Taavitsainen M
    Clin Exp Rheumatol; 1995; 13(6):733-6. PubMed ID: 8835246
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.
    Nuver-Zwart IH; van Riel PL; van de Putte LB; Gribnau FW
    Ann Rheum Dis; 1989 May; 48(5):389-95. PubMed ID: 2567150
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of psoriatic arthritis with sulphasalazine: a one year open study.
    Farr M; Kitas GD; Waterhouse L; Jubb R; Felix-Davies D; Bacon PA
    Clin Rheumatol; 1988 Sep; 7(3):372-7. PubMed ID: 2906579
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulphasalazine therapy in rheumatoid arthritis. A two-year study and follow-up of clinical results.
    Georgescu C
    Rom J Intern Med; 1992; 30(2):127-32. PubMed ID: 1353901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disease-modifying anti-rheumatic drugs in rheumatoid arthritis and ankylosing spondylitis.
    Haibel H; Specker C
    Clin Exp Rheumatol; 2009; 27(4 Suppl 55):S159-63. PubMed ID: 19822065
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A new strategy of drug treatment in NSAID-unresponsive ankylosing spondylitis: combination of pamidronate and methylprednisolone monthly intravenous infusions on the background of a combination of disease modifying drugs sulfasalazine and methotrexate.
    Malaviya AN; Kapoor S; Garg S; Ahmad I; Raja RR
    J Assoc Physicians India; 2007 Mar; 55():193-7. PubMed ID: 17598330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies.
    Burgos-Vargas R; Vázquez-Mellado J; Pacheco-Tena C; Hernández-Garduño A; Goycochea-Robles MV
    Ann Rheum Dis; 2002 Oct; 61(10):941-2. PubMed ID: 12228171
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.